The treatment of advanced renal cell cancer with high-dose oral thalidomide
Open Access
- 2 October 2001
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 85 (7), 953-958
- https://doi.org/10.1054/bjoc.2001.2025
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Hypothesis: Thalidomide embryopathy?proposed mechanism of actionTeratology, 2000
- Thalidomide — A Revival StoryThe New England Journal of Medicine, 1999
- Antitumor Activity of Thalidomide in Refractory Multiple MyelomaThe New England Journal of Medicine, 1999
- Inflammatory Bowel Disease ManagementDrugs, 1997
- Reciprocal paracrine interactions between tumour cells and endothelial cells: the ‘angiogenesis progression’ hypothesisEuropean Journal of Cancer, 1996
- Prurigo nodularis and photosensitivity in AIDS: Treatment with thalidomideJournal of the American Academy of Dermatology, 1995
- Thalidomide is an inhibitor of angiogenesis.Proceedings of the National Academy of Sciences of the United States of America, 1994
- Rapid Cytokine Release in Cancer Patients Treated with Interleukin-2Journal of Immunotherapy, 1992
- Interleukin-6 and renal cell cancer: Production, regulation, and growth effectsCancer Immunology, Immunotherapy, 1992
- Tumor Angiogenesis: Therapeutic ImplicationsThe New England Journal of Medicine, 1971